In 2021, the market for Nebulizer worldwide was worth $ 1.08 billion US dollars. AMR Group projects that the market will reach US$ 2.11 billion by 2031, growing at a CAGR of 7.2 percent between 2022 and 2031.

Industry Overview

Nebulizers are medical equipment used to administer medication by misting it into the lungs. Nebulizing devices create a thin mist of liquid medicine by pressuring compressed air through it, which is then inhaled through a mouthpiece or mask by the patient. These devices are designed for the treatment of respiratory conditions like asthma, COPD, and asthma cystic fibrosis. Basically, these devices are utilized in Nebulization is a frequent therapy method for respiratory conditions such asthma, cystic fibrosis, and COPD. Nebulization is done with a variety of equipment. The most popular devices are electrically powered and rechargeable. To create an aerosol, jet nebulizers employ pressurized gas (tiny particles of medication in the air). With the use of a face mask or mouthpiece, a patient can breathe in a thin mist of liquid medication created by a jet nebulizer. The main benefit of jet nebulizers is that they work well and simply require tidal breathing, which is easy to do. Additionally, dose compounding and customization are feasible with jet nebulizers.

Nebulizer and respiratory device markets are fairly developed, with jets dominating due to their low price. As a result, fierce competition is anticipated for additional nebulization devices. Furthermore, it is difficult for new technologies or devices to take off in developed markets, especially given the complexity of several national regulatory and reimbursement systems that must be adhered to for both medications and devices. By nature, Medicare considers nebulizers to be durable medical equipment. Government and non-government groups are taking steps to simplify the evaluation and treatment of respiratory illnesses, which will boost market expansion.

Market Dynamics

The global nebulizers market is expanding as a result of a rise in the number of respiratory illnesses and an ageing population. The adoption of portable nebulizers is just another factor driving the market. Nebulization is a spraying technique, hence the main factor limiting the growth of this market is the diffusion and drug waste that occurs during delivery to the respiratory system. Asthma is a serious non-communicable disease (NCD) that affects both children and adults, according to the WHO report from 2021. According to the same report, asthma affects 262 million people worldwide. As a result, the use of jet nebulizer treatments is necessary due to the growing prevalence of asthma, which in turn is driving the market's growth.

Technological advancements are driving the Nebulizers market by providing the development of more advanced devices that incorporate advanced technologies & materials. These advancements gave a higher effectiveness and safety of Nebulizers. High Demand for Lightweight, Transparent Devices and Shatter-resistant. This can be ascribed to technological advancements, advantages, and rise in launching of new products. In 2018, Philips launched InnoSpire Go, small-sized, portable, and light-weight mesh nebulizer that administers the drugs in just few minutes. Furthermore, risk of disease transmission and availability of alternate treatment options to limit the product adoption is a factor that is likely to hamper the growth of the Nebulizer which may restrain the market growth.

COVID Impact

The COVID-19 pandemic gave a positive impact on the Nebulizer business market. The outburst of the COVID-19 pandemic across the globe influenced the demand for devices to efficiently control the spread of this respiratory infection. Also, several key players exhibited elevated growth during the pandemic. In 2021, the business segment of Koninklijke Philips N.V. connected care, generated a revenue of USD 6,628.6 million and as coronavirus cases accelerated, many countries faced a crucial shortage of ventilators and meter dose inhalers. This shortage influenced to increased demand for the equipment used for management of critical care conditions such as ventilators, pulse oximeters, and others. This shortage of ventilators forced healthcare professionals to use other respiratory devices such as nebulizers, Continuous Positive Airway Pressure (CPAP), and oxygen concentrators causing its demand in market. In March 2020, the American College of Allergy, Asthma and Immunology in the U.S., found that the prescription rate of nebulizers increased during the pandemic as there was a shortage of metered dose inhalers.

Regional Trend

Geographically, North America dominated the Nebulizer market and had the largest revenue share of USD 382.7 million in 2021. The growth in this region can be attributed to due to A higher prevalence of asthma, other chronic respiratory conditions, and the rising adoption of advanced portable ones in the region have been instrumental in a higher market share of North America. According to the reports published by the Asthma & Allergy Foundation of America in 2021, found that around 25 million people in the U.S. were diagnosed with asthma. Moreover, Europe is the second-most dominant region in terms of revenue and nebulizer market share. The only reason associated for the growth of the nebulizer market in Europe is the increasing incidences of respiratory diseases and infections, adding up to increasing demand for these devices in the Europe market.

Asia Pacific region is expected to present outstanding Nebulizers market opportunities due to the rising prevalence of chronic respiratory diseases, improving healthcare infrastructure and the growing number of medical device. Companies are developing inhaled drug delivery devices to treat asthma and COPD in these regions. Rise in awareness among parents about the potential long-term effects of respiratory distress in patients has enhanced the emphasis on early diagnosis & treatment.

Competitive Landscape

Key players operating in the Nebulizer Market include Aerogen, Agilent Technologies, Inc. Ltd, Allied Healthcare, Beurer GmBH, Briggs Healthcare, CareFusion Corporation, Covidien plc, DeVilbiss Healthcare LLC, GE Healthcare, GF Health Products, Inc., Koninklijke Philips N.V., Omron Healthcare Co., PARI Respiratory Equipment, Inc., Philips Healthcare, and Vectura Group Plc. among others. In July 2020, Omron Healthcare introduced a compressor nebulizer in India, named OMRON NE C106. This device features a range of advanced technologies designed to help healthcare professionals accurately and safely treat patients with respiratory distress.

Key USP’s-

According to the WHO (World Health Organization), approx. 65 million people across the globe suffers from COPD and around 3 million deaths occurs due to COPD every year. Additionally, around 262 million people across the globe were affected with asthma in 2019, and it caused 461,000 deaths in the same year.

Market Segmentation

Based upon the Type used in the Nebulizer market is segmented in Jet, Mesh and Ultrasonic. The Jet type dominated the Nebulizers market in 2021. Jet nebulizers are to low cost compared to the other devices. Besides, it is ease to handle jet nebulizers and efficient design for drug delivery has made jet nebulizers the prime segment over the years. Based on the application, the Nebulizer market is segmented into COPD, Cystic Fibrosis and Asthma. In the application segment the most dominant market is COPD which requires the largest Nebulizers market share in 2021. This segment is driven by the increasing prevalence of COPD. Based on the modality, the Nebulizer market is segmented into portable and table top nebulizers.

End user segment of Nebulizer market is further bifurcated into Hospitals and Clinics, Emergency Centers and Home Healthcare. The hospitals and clinics segment held major share of the global market in 2021. Demand for medical equipment, including Nebulizers, is high in hospitals & clinics due to the rising number of patients visiting for treatment.

By Type

·         Jet

·         Mesh

o   Active

o   Passive

·         Ultrasonic

By Application

·         COPD

·         Cystic Fibrosis

·         Asthma

By Modality

·         Portable

·         Table-top

By End User

·         Hospitals and Clinics

·         Emergency Centers

·         Home Healthcare